Skip to main navigation
TCR2 Staging

Corporate Menu & Investor Relations

Contact Patients
Mission Leadership Community
The TCR Complex Therapeutic Approach TRuC-T Advantages Manufacturing Publications
Overview TC-210 TC-110 Pipeline
Press Releases In the News Awards
Overview Events Presentations Corporate Governance SEC Filings Stock Information Analyst Coverage FAQs
Careers
investors.jpg
TCR2 Investors

Corporate Menu & Investor Relations

About Us Mission Leadership Community Technology The TCR Complex Therapeutic Approach TRuC-T Advantages Manufacturing Publications Programs Overview TC-210 TC-110 Pipeline News Press Releases In the News Awards Investors Overview Events Presentations Corporate Governance SEC Filings Stock Information Analyst Coverage FAQs Careers Careers Contact Patients

Press Releases

Latest Press Releases | In The News

Press Releases

All News | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |

Nov 09, 2017

TCR² Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference 172.5 KB

Nov 02, 2017

TCR² Therapeutics Appoints Cell Therapy Pioneer Dr. Stephan Grupp to Advisory Board 213 KB

Oct 31, 2017

TCR² Therapeutics to Present New Data from its TRuC™ T Cell Programs at the Society for Immunotherapy of Cancer (SITC) Annual 276.9 KB

Oct 11, 2017

TCR² Therapeutics Appoints Leading Cell Therapy Expert as Chief Medical Officer 189.5 KB

Sep 15, 2017

TCR² Therapeutics Named One of the 15 Innovative Immuno-Oncology Biotechs to Watch in 2018 by Immuno-Oncology Frontiers 300.8 KB

Aug 29, 2017

TCR² Therapeutics to Present Solid Tumor Data at CAR-TCR Summit and CRI-CIMT-EATI-AACR International Cancer Immunotherapy 210.1 KB

Aug 08, 2017

TCR² Therapeutics to Present at the 2017 Wedbush PacGrow Healthcare Conference 172.6 KB

Jun 13, 2017

TCR² Therapeutics Presents Positive Solid Tumor Data for its Novel TRuC™ Engineered T Cell Therapies at the World Preclinical 365.3 KB

May 16, 2017

TCR² Therapeutics to Present at the 2017 UBS Global Healthcare Conference 171.1 KB

Feb 28, 2017

TCR² Therapeutics to Present at the Cowen and Company 37th Annual Health Care Conference 286.5 KB

Tools

  • Print Page
  • RSS Feeds
  • Email Alerts
  • Contact IR
TCR2
 

100 Binney Street, Suite 710
Cambridge, MA 02142
617.949.5200

TERMS OF USE

Corporate Menu & Investor Relations

About Us
Technology
Programs
News
Investors
Careers
Contact
Patients